Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	0.86	58.36	57.86
Graham Fair Price	-41.19	187.18	318.29
PEG	-1978.04	-0.27	-0.01
Price/Book	15.44	1.59	1.38
Price/Cash Flow	65.50	146.97	88.80
Prices/Earnings	247.69	17.86	5.14
Price/Sales	22.12	10.10	8.27
Price/FCF	65.50	146.97	88.80
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.61	0.22	0.19
Operating Margin	22.45	0.15	0.13
ROA	-66.20	0.01	0.04
ROE	0.07	0.02	-66.80
ROIC	0.01	0.02	18.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.03	53.78
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.11	0.18	61.36
EPS QOQ	3.95	-0.66	-83.27
FCF QOQ	0.04	-0.29	643.72
Revenue QOQ	< 0.005	-0.04	2008.89
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	28.76	30.24	5.16
Days Sales Outstanding (DSO)	42.60	78.38	83.99
Inventory Turnover	3.13	2.98	-4.91
Debt/Capitalization	0.19	0.18	-4.95
Quick Ratio	39.71	4.90	-87.67
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	259.35	264.69	2.06
Cash	77.46	87.54	13.00
Capex	-2.64	-2.03	22.86
Free Cash Flow	4.02	2.86	-28.81
Revenue	43.15	41.62	-3.53
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	39.71	5.33	-86.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.06	5.12	-15.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating